These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 11290583

  • 1. A common epitope is shared by activated signal transducer and activator of transcription-5 (STAT5) and the phosphorylated erythropoietin receptor: implications for the docking model of STAT activation.
    Barber DL, Beattie BK, Mason JM, Nguyen MH, Yoakim M, Neel BG, D'Andrea AD, Frank DA.
    Blood; 2001 Apr 15; 97(8):2230-7. PubMed ID: 11290583
    [Abstract] [Full Text] [Related]

  • 2. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
    Chin H, Arai A, Wakao H, Kamiyama R, Miyasaka N, Miura O.
    Blood; 1998 May 15; 91(10):3734-45. PubMed ID: 9573010
    [Abstract] [Full Text] [Related]

  • 3. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.
    Chin H, Wakao H, Miyajima A, Kamiyama R, Miyasaka N, Miura O.
    Blood; 1997 Jun 15; 89(12):4327-36. PubMed ID: 9192755
    [Abstract] [Full Text] [Related]

  • 4. Physical and functional interactions between Stat5 and the tyrosine-phosphorylated receptors for erythropoietin and interleukin-3.
    Chin H, Nakamura N, Kamiyama R, Miyasaka N, Ihle JN, Miura O.
    Blood; 1996 Dec 15; 88(12):4415-25. PubMed ID: 8977232
    [Abstract] [Full Text] [Related]

  • 5. Multiple tyrosine residues in the cytosolic domain of the erythropoietin receptor promote activation of STAT5.
    Klingmüller U, Bergelson S, Hsiao JG, Lodish HF.
    Proc Natl Acad Sci U S A; 1996 Aug 06; 93(16):8324-8. PubMed ID: 8710869
    [Abstract] [Full Text] [Related]

  • 6. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
    Okutani Y, Kitanaka A, Tanaka T, Kamano H, Ohnishi H, Kubota Y, Ishida T, Takahara J.
    Oncogene; 2001 Oct 04; 20(45):6643-50. PubMed ID: 11641791
    [Abstract] [Full Text] [Related]

  • 7. Regulation of erythropoietin-induced STAT serine phosphorylation by distinct mitogen-activated protein kinases.
    Haq R, Halupa A, Beattie BK, Mason JM, Zanke BW, Barber DL.
    J Biol Chem; 2002 May 10; 277(19):17359-66. PubMed ID: 11875080
    [Abstract] [Full Text] [Related]

  • 8. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
    Tong W, Zhang J, Lodish HF.
    Blood; 2005 Jun 15; 105(12):4604-12. PubMed ID: 15705783
    [Abstract] [Full Text] [Related]

  • 9. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S, Ichikawa H, Okada T, Sarai A, Sugimoto T, Morimoto H, Kihara T, Yano A, Nakao K, Nagake Y, Wada J, Makino H.
    J Am Soc Nephrol; 2004 Dec 15; 15(12):3215-24. PubMed ID: 15579525
    [Abstract] [Full Text] [Related]

  • 10. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells.
    Yamamura Y, Senda H, Kageyama Y, Matsuzaki T, Noda M, Ikawa Y.
    Mol Cell Biol; 1998 Mar 15; 18(3):1172-80. PubMed ID: 9488432
    [Abstract] [Full Text] [Related]

  • 11. The role of erythropoietin receptor tyrosine phosphorylation in erythropoietin-induced proliferation.
    Damen JE, Liu L, Wakao H, Miyajima A, Rosten P, Jefferson AB, Majerus PW, Krosl J, Humphries RK, Krystal G.
    Leukemia; 1997 Apr 15; 11 Suppl 3():423-5. PubMed ID: 9209412
    [Abstract] [Full Text] [Related]

  • 12. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A, Arai K.
    Oncologist; 1996 Apr 15; 1(5):337-339. PubMed ID: 10388012
    [Abstract] [Full Text] [Related]

  • 13. APS, an adaptor protein containing Pleckstrin homology (PH) and Src homology-2 (SH2) domains inhibits the JAK-STAT pathway in collaboration with c-Cbl.
    Wakioka T, Sasaki A, Mitsui K, Yokouchi M, Inoue A, Komiya S, Yoshimura A.
    Leukemia; 1999 May 15; 13(5):760-7. PubMed ID: 10374881
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Roles for an Epo receptor Tyr-343 Stat5 pathway in proliferative co-signaling with kit.
    Li K, Miller C, Hegde S, Wojchowski D.
    J Biol Chem; 2003 Oct 17; 278(42):40702-9. PubMed ID: 12909618
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
    Arcasoy MO, Harris KW, Forget BG.
    Exp Hematol; 1999 Jan 17; 27(1):63-74. PubMed ID: 9923445
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association of CrkL with STAT5 in hematopoietic cells stimulated by granulocyte-macrophage colony-stimulating factor or erythropoietin.
    Ota J, Kimura F, Sato K, Wakimoto N, Nakamura Y, Nagata N, Suzu S, Yamada M, Shimamura S, Motoyoshi K.
    Biochem Biophys Res Commun; 1998 Nov 27; 252(3):779-86. PubMed ID: 9837784
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.